Cory Perla

CHICAGO — In this video, Karl G. Csaky, MD, PhD, discusses highlights from the AAO annual meeting.In a panel discussion on dry age-related macular degeneration, experts debated the importance of anatomic vs. functional benefits of dry AMD therapies, according to Csaky, chief executive and medical officer of the Retina Foundation of the Southwest in Dallas.

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses controversies surrounding the use of complement inhibitors for the treatment of geographic atrophy.

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses highlights from the AAO meeting.

In this video, Barbara Blodi, MD, discusses results from the ARCHER trial presented at the American Society of Retina Specialists annual meeting.

In this video, Barbara Blodi, MD, discusses advancements in complement inhibition treatments for geographic atrophy.At the ASRS annual meeting, there were panel discussions about the pros and cons of these types of therapies, Blodi said.

In this video, Barbara Blodi, MD, discusses the importance of the ellipsoid zone as a biomarker in patients with geographic atrophy.“There are now AI systems that can measure the ellipsoid zone — its presence or absence or disruption,” Blodi said during a recap about presentations from the ASRS annual meeting.

In this video, Barbara Blodi, MD, discusses advancements in gene therapy for the treatment of age-related macular degeneration.At the ASRS annual meeting, several sessions revolved around gene therapy in clinical trials from various companies and delivery of the therapy.

Pegcetacoplan may be a more effective treatment option than avacincaptad pegol for reducing geographic atrophy lesion growth in patients with age-related macular degeneration.The study, presented at the American Society of Retina Specialists annual meeting by Paul Hahn, MD, PhD, FASRS, a retina specialist at NJRetina, compared intravitreal pegcetacoplan (PEG) vs. avacincaptad pegol (ACP) for the

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses a presentation at the ARVO annual meeting on patient preferences for retinal prosthesis options.

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses an update on the use of anti-VEGF biosimilars for the treatment of age-related macular degeneration.